MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF | |
Li, B.[1,2,3,10]; Xu, W. W.[1,2,11]; Han, L.[1,2]; Chan, K. T.[4]; Tsao, S. W.[1,3]; Lee, N. P. Y.[3,4]; Law, S.[3,4]; Xu, L. Y.[5]; Li, E. M.[5]; Chan, K. W.[3,6] | |
2017 | |
卷号 | 36期号:[db:dc_citation_issue]页码:3986 |
DOI | [db:dc_identifier_doi] |
URL标识 | 查看原文 |
WOS记录号 | [DB:DC_IDENTIFIER_WOSID] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3330452 |
专题 | 暨南大学 |
作者单位 | 1.[1]Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China 2.[2]Univ Hong Kong, Shenzhen Inst Res & Innovat HKU SIRI, Shenzhen, Peoples R China 3.[3]Univ Hong Kong, Ctr Canc Res, Pokfulam, Peoples R China 4.[4]Univ Hong Kong, Dept Surg, Pokfulam, Peoples R China 5.[5]Shantou Univ Med Coll, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Peoples R China 6.[6]Univ Hong Kong, Dept Pathol, Pokfulam, Peoples R China 7.[7]Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou, Peoples R China 8.[8]Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Pokfulam, Peoples R China 9.[9]Jinan Univ, Coll Life Sci & Technol, 601 West Huangpu Blvd, Guangzhou, Guangdong, Peoples R China 10.[10]Jinan Univ, Coll Life Sci & Technol, 601 West Huangpu Blvd, Guangzhou 510632, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Li, B.[1,2,3,10],Xu, W. W.[1,2,11],Han, L.[1,2],et al. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF[J],2017,36([db:dc_citation_issue]):3986. |
APA | Li, B.[1,2,3,10].,Xu, W. W.[1,2,11].,Han, L.[1,2].,Chan, K. T.[4].,Tsao, S. W.[1,3].,...&Cheung, A. L. M.[1,2,3].(2017).MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.,36([db:dc_citation_issue]),3986. |
MLA | Li, B.[1,2,3,10],et al."MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF".36.[db:dc_citation_issue](2017):3986. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论